Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Levered Free Cash Flow (FCF)

Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Levered Free Cash Flow (FCF) from 2018 to 2018.
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the last 12 months ending December 12, 2018 was $76m a 230.88% increase of 176m year over year
  • Amneal Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2018 was $76m a 14.65% increase of 11m from 2017
  • Amneal Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2017 was $65m a 253.34% increase of 165m from 2016
  • Amneal Pharmaceuticals Inc Annual Levered Free Cash Flow (FCF) for 2016 was $-100m
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Levered Free Cash Flow (FCF) Data

12/2018$215m
09/2018$41m
06/2018$-15m
03/2018$13m

Annual AMRX Levered Free Cash Flow (FCF) Data

2018$76m
2017$65m
2016$-100m